Call Start: 16:30 January 1, 0000 5:37 PM ET

Agilent Technologies, Inc. (NYSE:A)
Q4 2024 Earnings Conference Call
November 25, 2024 04:30 PM ET

Company Participants

Parmeet Ahuja - Vice President, Investor Relations
Padraig McDonnell - President and CEO
Bob McMahon - Senior Vice President and CFO
Simon May - President, Life Sciences and Diagnostic Markets Group
Phil Binns - President, Life Sciences & Applied Markets Group
Angelica Riemann - President, Agilent CrossLab Group
Mike Zhang - President, Applied Markets Group

Conference Call Participants

Patrick Donnelly - Citi
Matt Sykes - Goldman Sachs
Rachel Vatnsdal - JPMorgan
Vijay Kumar - Evercore ISI
Jack Meehan - Nephron Research
Dan Leonard - UBS
Puneet Souda - Leerink Partners
Tycho Peterson - Jefferies
Brandon Couillard - Wells Fargo
Doug Schenkel - Wolfe Research
Michael Ryskin - Bank of America
Dan Brennan - TD Cowen

Operator

Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agilent Technologies Inc. Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]

Thank you. Prameet Ahuja, you may begin your conference.

Parmeet Ahuja

Thank you and welcome, everyone, to Agilent's conference call for the fourth quarter of fiscal year 2024.

I'm sure you've seen our press release earlier today regarding our new market-focused organizational structure, which we will talk about in more detail. These changes have no impact on our company's consolidated financial statements. All financial metrics and guidance during this call will be shared under our historical structure. We will provide recast historical segment information to reflect these changes ahead of our upcoming Investor Day.

Now onto our quarterly results. With me are Padraig McDonnell, Agilent's President and CEO; and Bob McMahon, Agilent's Senior Vice President and CFO.

Joining in the Q&A will be Phil Binns, President of the former Life Sciences and Applied Markets Group; Simon May, President of the newly formed Life Sciences and Diagnostic Markets Group; and Angelica Riemann, President of the expanded Agilent CrossLab Group. Also joining the call is Mike Zhang, President of the newly formed Applied Markets Group.

This presentation is being webcast live. The news release for our fourth quarter financial results, investor presentation and information to supplement today's discussion, along with the recording of this webcast are available on our website at www.investor.agilent.com.